Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT05769842 Completed - Clinical trials for Airway Complication of Anesthesia

Effects of Propofol on Respiratory Adverse Events During Extubation in Children Undergoing Tonsil Adenoidectomy

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

The main objective of this study was to investigate whether propofol assisted extubation could reduce the incidence of respiratory adverse events in children with tonsil adenoidectomy.

NCT ID: NCT05768243 Completed - Clinical trials for Periodontitis Chronic Generalized Severe

Hyaluronic Acid Versus Red Injectable Platelet Rich Fibrin in Treatment of Periodontitis

Start date: March 1, 2021
Phase: Phase 4
Study type: Interventional

the aim of this clinical trial is to compare the efficacy of hyaluronic acid (HA) used as an adjunctive to scaling and root planing (SRP) and red injectable platelet rich-fibrin (i-PRF) in the non-surgical treatment of stage III periodontitis. The main question it aims to answer is: is there a difference between HA and red i-prf when used as an adjunct to SRP in terms of efficacy? Participants who are eligible will be assigned to one of the treatment groups: - Group 1= receives HA+ SRP - Group 2= receives red i-prf + SRP - Group 3= receives only SRP Researchers will compare Groups 1,2 and 3 to see if there's a difference in the periodontal parameters measured.

NCT ID: NCT05767918 Completed - Clinical trials for Pulmonary Hypertension

StratosPHere (Non-interventional Study)

Start date: April 14, 2021
Phase:
Study type: Observational

Pulmonary Arterial Hypertension is a progressive disease that has no cure. Patients die young and are limited in their daily activity. Current treatments only treat the symptoms of the disease rather than the underlying cause. At least 1 in 5 patients has a change in a gene called the bone morphogenetic type 2 protein (or BMPR2). Extensive evidence supports the concept of addressing the reduced levels of the BMPR2 protein to reverse disease. Through work already undertaken by this group, two potential therapies which increase BMPR2 have been identified for use in a future randomised control trial. In order for a clinical trial to be informative we need an accurate way of measuring the protein or the effects of the protein (known as a biomarker). This study will use blood samples taken from 17 patients and 30 healthy participants over various time-points (2-5 visits over 5 weeks for healthy controls; 2 visits, approximately four months apart for patients). Laboratory work will help identify the best biomarkers for subsequent therapy studies. By defining the best biomarkers we can speed up the drug development in this rare disease.

NCT ID: NCT05765994 Completed - Critical Illness Clinical Trials

Small Intestinal Bacterial Overgrowth in Critically Ill Patients

Start date: November 19, 2018
Phase:
Study type: Observational

Small intestinal bacterial overgrowth (SIBO) syndrome, though associated with potentially serious complications, has not been adequately studied to date in critically ill patients hospitalized in intensive care units (ICU). A modified method for SIBO diagnosis is employed concerning a standard breath test. Specifically, as all participants are intubated and in need of mechanical ventilation, SIBO diagnosis is based on a non-invasive modified technique for sampling exhaled air from the ventilator tubes and performing a standard hydrogen breath test. The primary objective of this study is assessment of the prevalence of SIBO on ICU patients. Secondary outcomes include investigation of the effects of SIBO on ventilator associated pneumonia, as well as ICU length of stay and all-cause in-hospital mortality rate in critically ill patients.

NCT ID: NCT05763264 Completed - Contraception Clinical Trials

TITLE SAGCS2 Protocol 2.3 + Amend 1

Start date: October 12, 2020
Phase: N/A
Study type: Interventional

The clinical study will compare two lubricated polyurethane male condoms of different thickness with a marketed lubricated control male condom made of natural rubber latex. This crossover study will randomize 300 heterosexual couples to the sequence in which they use five condoms of each of the three study condom types. The clinical failure (breakage and slippage) rates of the two polyurethane condoms will be compared to the clinical failure (breakage and slippage) rate of commercial natural rubber latex control condom using a statistical test of non-inferiority. The study will also compare the acceptability of the two polyurethane condom different thickness with that of the natural rubber latex control condom obtained from interviews and questionnaires with subject couples.

NCT ID: NCT05763238 Completed - Quality of Life Clinical Trials

Exercise Training in Children With Corrective Cardiac Surgeries

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

To determine the effects of preoperative exercise therapy on postoperative cardiopulmonary outcomes and quality of life in children with corrective cardiac surgeries.Within literature there is limited evidence on preoperative exercise therapy in the pediatric population, positive results of the study can introduce a new tradition of preoperative exercise therapy and significantly reduce post-operative complications. Secondary complications would also be addressed in the study, a positive result can reduce the total costs by reducing hospital stays and improving the quality of life of child.

NCT ID: NCT05761990 Completed - Clinical trials for Glenohumeral Internal Rotation Deficit

Novel Stretching Versus Post Isometric Relaxation Techniques On Shoulder Disability In Athletes

Start date: July 17, 2022
Phase: N/A
Study type: Interventional

It was a randomized control trial in which thirty (30) participants having GRID, age between 20-40 years were randomly allocated into two groups i-e NS (Novel stretching) Group (30) and PIR (posterior isometric relaxation techniques) Group (30), February 2022 to March 2022.PIR group received the posterior isometric relaxation techniques (three times a week for one month) and NS group received the Novel stretching (three times a week for one month). IR ROM was measured with a goniometer while pain was measured with Numeric Pain Rating Scale intervention and disability of arm, shoulder and hand was measured with DASH score before, immediately, and at week 4 post intervention.

NCT ID: NCT05761626 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Mechanical Power and Ventilatory Ratio in ARDS

Start date: March 1, 2016
Phase:
Study type: Observational

Mechanical power (MP) and ventilatory ratio (VR) are variables associated with outcomes in patients with acute respiratory distress syndrome (ARDS). In respiratory setting, the optimization of MP should lead to an increase in VR. Therefore, the objectives of this study are: to assess the relationship between MP and VR and to compare the components of MP (ventilatory variables) according to a level of MP (17 J/minute) considered harmful.

NCT ID: NCT05758051 Completed - Clinical trials for Slipped Capital Femoral Epiphysis

Management of Slipped Capital Femoral Epiphysis (SCFE) on Top of Fixed Fracture Neck of Femur Case Report.

SCFE
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Slipped Capital Femoral Epiphysis (SCFE) on Top of Fixed Fracture Neck of Femur managed by subtrochanteric valgus osteotomy

NCT ID: NCT05757193 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction

Ketone Pharmacokinetic Study in HFrEF

Start date: June 2, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test whether an over-the-counter ketone ester drink is well tolerated in people with heart failure on, and not on, a heart failure medication class called SGLT2 inhibitors. The research team is trying to determine the safest dose of Delta G. The study has a single visit. Participants will be served a light breakfast with the study drink, a physical exam will be conducted, and the study team will obtain information about demographics and medical history. The study team will draw blood intravenously up to eight times over the course of the half-day visit.